Clinical Equivalence Study of Mometasone Nasal Spray
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare
the Clinical Equivalence of Mometasone Nasal Spray (Watson Laboratories, Inc) with NASONEX®
Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal
Allergic Rhinitis